Alyeska Investment Group’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-236,425
Closed -$63.9M 611
2025
Q3
$63.9M Buy
+236,425
New +$64.3M 0.19% 142
2024
Q3
Sell
-22,991
Closed -$4.52M 557
2024
Q2
$4.52M Buy
22,991
+1,672
+8% +$345K 0.03% 349
2024
Q1
$4.59M Sell
21,319
-103,887
-83% -$21.8M 0.03% 333
2023
Q4
$26.4M Buy
+125,206
New +$26.7M 0.17% 167
2022
Q3
Sell
-89,642
Closed -$18.4M 396
2022
Q2
$18.4M Buy
+89,642
New +$19M 0.21% 153
2021
Q4
Sell
-1,684
Closed -$326K 620
2021
Q3
$326K Buy
+1,684
New +$341K ﹤0.01% 649
2019
Q2
Sell
-1,911
Closed -$315K 453
2019
Q1
$315K Buy
+1,911
New +$338K ﹤0.01% 358
2018
Q4
Sell
-335,876
Closed -$57.2M 378
2018
Q3
$57.2M Sell
335,876
-50,619
-13% -$8.52M 0.63% 55
2018
Q2
$63.4M Buy
+386,495
New +$63.1M 0.57% 63
2016
Q3
Sell
-77,824
Closed -$7.58M 467
2016
Q2
$7.58M Buy
+77,824
New +$7.35M 0.07% 270
2016
Q1
Sell
-22,190
Closed -$2.01M 398
2015
Q4
$2.01M Sell
22,190
-355,115
-94% -$33.4M 0.02% 307
2015
Q3
$35M Buy
377,305
+363,535
+2,640% +$34.6M 0.41% 90
2015
Q2
$1.28M Buy
+13,770
New +$1.28M 0.01% 391

Other funds holding CME

Alyeska Investment Group's CME Position: Q4 2025 in Review

Alyeska Investment Group sold out of CME Group (CME) in Q4 2025, closing a stake of 236,425 shares — an estimated $63.9M sold.

Alyeska Investment Group first reported a position in CME in Q2 2015 and held it in 13 quarters. The position peaked at $63.9M in Q3 2025. 1,736 funds tracked by Wall St. Rank hold CME as of Q4 2025.

  • Alyeska Investment Group reported no remaining CME Group position as of Q4 2025 after selling out during the quarter.
  • Alyeska Investment Group sold 236,425 CME Group shares in Q4 2025, an estimated $63.9M.
  • Alyeska Investment Group first reported a position in CME Group in Q2 2015 and held it in 13 quarters.
  • Alyeska Investment Group's CME Group position peaked at $63.9M in Q3 2025.
  • 1,736 funds tracked by Wall St. Rank held CME Group as of Q4 2025.

Based on Alyeska Investment Group's 13F filing for Q4 2025, filed 13 Feb 2026.